Beam Therapeutics is pioneering the use of proprietary base-editing technology to develop powerful, uniquely precise genetic machines that rewrite genetic code, one letter at a time.
Since its discovery in 2012 CRISPR-Cas9, a gene-editing technique, has gone from strength to strength. This tool, developed from a bacterial defence system that…
Read MoreGenetics is having a moment in the sun. Last year, biologists at the University of Bath in England created mice with neon feet.
Read MoreThe toolbox for editing genes expanded this week, as two research groups announced techniques that enable researchers to make targeted alterations to DNA and…
Read MoreStay on target. That’s the mantra you hear in labs and biotech companies around the world as they snip away at DNA.
Read More
The foundation of Beam’s work to develop precision genetic medicines is groundbreaking research coming out of the laboratories of our founders. Our base editing technologies were the subject of research published in Nature and Science in 2016 and 2017.